RO7297089
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RO7297089, covering 2024-07-03 to 2024-07-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study Evaluating The Safety And Pharmacokinetics Of Escalating Doses Of RO7297089 In Patients With Relapsed Or Refractory Multiple Myeloma [Phase 1]